Search results
The Bolivian people defeat another coup - Aliran
Aliran Online· 1 hour ago“No one can take away our democracy!” Bolivian President Luis Arce addressed the people of Bolivia on 26 June to declare that an attempted military coup had been defeated. On the afternoon of ...
Why Stocks Are On Pace For A Historic Second Half
Zacks via Yahoo News· 9 hours agoStocks recently finished a fantastic first half of 2024... and the best part is that there's more upside to come! So, it's not too late to take advantage...
Vistra (VST) Surges 136.2% Year to Date: Time to Buy the Stock?
Zacks via Yahoo News· 14 hours agoVistra's (VST) rising earnings estimates, better-than-industry returns and clean energy generation...
Should You Retain Regency (REG) Stock in Your Portfolio Now?
Zacks via Yahoo News· 14 hours agoOwnership of premium shopping centers and a healthy balance sheet will likely aid Regency (REG)...
Powell Industries (POWL) Up 70.4% YTD: What's Next for Investors?
Zacks via Yahoo News· 15 hours agoAlso, the stock is cheap compared with many of its peers like Eaton Corporation ETN and Schneider...
Disney (DIS) Gains 8.5% YTD: How Should You Play the Stock in 2H?
Zacks via Yahoo News· 15 hours agoDisney's (DIS) iconic brand and impressive media assets, on one hand, and competitive pressure and...
ASUS ROG NUC 970 review
PC Gamer via Yahoo News· 15 hours ago...Image credit: Future) CPU: Intel Core 9 Ultra 185H GPU: Nvidia RTX 4070 Mobile Memory: 32GB DDR5 5600 Storage: 1TB PCI-E Gen4 M.2 SSD Wireless: Intel...
5 Financial Transaction Stocks in Focus Amid Digital Payment Boom
Zacks via Yahoo News· 16 hours agoThe Financial Transaction Services industry benefits from digital adoption, strong consumer spending...
Amazon (AMZN) Up 30.1% YTD on Retail Strength: Should You Buy?
Zacks via Yahoo News· 16 hours agoAmazon AMZN has experienced a 30.1% surge in its stock price year to date (YTD), outperforming the...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo News· 16 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
